Ontology type: schema:ScholarlyArticle
2019-04-08
AUTHORSMaryam Tabesh, Dianna J Magliano, Stephanie K Tanamas, Filip Surmont, Silver Bahendeka, Chern-En Chiang, Jorge F Elgart, Juan J Gagliardino, Sanjay Kalra, Satheesh Krishnamoorthy, Andrea Luk, Hiroshi Maegawa, Ayesha A Motala, Fraser Pirie, Ambady Ramachandran, Khaled Tayeb, Olga Vikulova, Jencia Wong, Jonathan E Shaw
ABSTRACTAIMS: The impact of introducing new classes of glucose-lowering medication (GLM) on diabetes management remains unclear, especially outside North America and Western Europe. Therefore, we aimed to analyse trends in glycaemic control and the usage of new and old GLMs in people with type 2 diabetes from 2006 to 2015. METHODS: Summary data from clinical services from nine countries outside North America and Western Europe were collected and pooled for statistical analysis. Each site summarized individual-level data from out-patient medical records for 2006 and 2015. Data included: demographics; HbA1c and fasting plasma glucose levels; and the proportions of patients taking GLM as monotherapy, combination therapy and/or insulin. RESULTS: Between 2006 and 2015, glycaemic control remained stable, although body mass index and duration of diabetes increased in most sites. The proportion of people on GLM increased, and the therapeutic regimens became more complex. There were increases in the use of insulin and triple therapy in most sites, while monotherapy, particularly in relation to sulphonylureas, decreased. Despite the introduction of new GLMs, such as DPP-4 inhibitors, insulin use increased over time. CONCLUSIONS: There was no clear evidence that the use of new classes of GLMs was associated with improvements in glycaemic control or reduced the reliance on insulin. These findings were consistent across a range of economic and geographic settings. More... »
http://scigraph.springernature.com/pub.10.1007/s00592-018-01284-4
DOIhttp://dx.doi.org/10.1007/s00592-018-01284-4
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1113301040
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/30963308
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Monash University",
"id": "https://www.grid.ac/institutes/grid.1002.3",
"name": [
"Baker Heart and Diabetes Institute, Level 4, Alfred Centre, 99 Commercial Road, Melbourne, VIC, 3004, Australia. maryam.tabesh@baker.edu.au.",
"Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia. maryam.tabesh@baker.edu.au."
],
"type": "Organization"
},
"familyName": "Tabesh",
"givenName": "Maryam",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Monash University",
"id": "https://www.grid.ac/institutes/grid.1002.3",
"name": [
"Baker Heart and Diabetes Institute, Level 4, Alfred Centre, 99 Commercial Road, Melbourne, VIC, 3004, Australia.",
"Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia."
],
"type": "Organization"
},
"familyName": "Magliano",
"givenName": "Dianna J",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Baker IDI Heart and Diabetes Institute",
"id": "https://www.grid.ac/institutes/grid.1051.5",
"name": [
"Baker Heart and Diabetes Institute, Level 4, Alfred Centre, 99 Commercial Road, Melbourne, VIC, 3004, Australia."
],
"type": "Organization"
},
"familyName": "Tanamas",
"givenName": "Stephanie K",
"type": "Person"
},
{
"affiliation": {
"alternateName": "AstraZeneca (United Kingdom)",
"id": "https://www.grid.ac/institutes/grid.417815.e",
"name": [
"AstraZeneca, London, UK."
],
"type": "Organization"
},
"familyName": "Surmont",
"givenName": "Filip",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nsambya Hospital",
"id": "https://www.grid.ac/institutes/grid.461255.1",
"name": [
"MKPGMS-Uganda Martyrs University and St. Francis Hospital Nsambya, Kampala, Uganda."
],
"type": "Organization"
},
"familyName": "Bahendeka",
"givenName": "Silver",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Taipei Veterans General Hospital",
"id": "https://www.grid.ac/institutes/grid.278247.c",
"name": [
"General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan."
],
"type": "Organization"
},
"familyName": "Chiang",
"givenName": "Chern-En",
"type": "Person"
},
{
"affiliation": {
"alternateName": "National University of La Plata",
"id": "https://www.grid.ac/institutes/grid.9499.d",
"name": [
"Facultad de Ciencias M\u00e9dicas UNLP, CENEXA, Centro de Endocrinolog\u00eda Experimental y Aplicada (UNLP-CONICET), La Plata, Argentina."
],
"type": "Organization"
},
"familyName": "Elgart",
"givenName": "Jorge F",
"type": "Person"
},
{
"affiliation": {
"alternateName": "National University of La Plata",
"id": "https://www.grid.ac/institutes/grid.9499.d",
"name": [
"Facultad de Ciencias M\u00e9dicas UNLP, CENEXA, Centro de Endocrinolog\u00eda Experimental y Aplicada (UNLP-CONICET), La Plata, Argentina."
],
"type": "Organization"
},
"familyName": "Gagliardino",
"givenName": "Juan J",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Bharti Hospital",
"id": "https://www.grid.ac/institutes/grid.470178.d",
"name": [
"Bharti Research Institute of Diabetes and Endocrinology, Bharti Hospital, Karnal, Haryana, India."
],
"type": "Organization"
},
"familyName": "Kalra",
"givenName": "Sanjay",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Dr. A. Ramachandran's Diabetes Hospitals",
"id": "https://www.grid.ac/institutes/grid.468157.9",
"name": [
"Dr A Ramachandran's Diabetes Hospitals, Chennai, India."
],
"type": "Organization"
},
"familyName": "Krishnamoorthy",
"givenName": "Satheesh",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Prince of Wales Hospital",
"id": "https://www.grid.ac/institutes/grid.415197.f",
"name": [
"Department of Medicine and Therapeutics, Prince of Wales Hospital, Sha Tin, Hong Kong SAR, China."
],
"type": "Organization"
},
"familyName": "Luk",
"givenName": "Andrea",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Shiga University of Medical Science",
"id": "https://www.grid.ac/institutes/grid.410827.8",
"name": [
"Shiga University of Medical Science, Shiga, Japan."
],
"type": "Organization"
},
"familyName": "Maegawa",
"givenName": "Hiroshi",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of KwaZulu-Natal",
"id": "https://www.grid.ac/institutes/grid.16463.36",
"name": [
"Department of Diabetes and Endocrinology, University of KwaZulu Natal, Durban, South Africa."
],
"type": "Organization"
},
"familyName": "Motala",
"givenName": "Ayesha A",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of KwaZulu-Natal",
"id": "https://www.grid.ac/institutes/grid.16463.36",
"name": [
"Department of Diabetes and Endocrinology, University of KwaZulu Natal, Durban, South Africa."
],
"type": "Organization"
},
"familyName": "Pirie",
"givenName": "Fraser",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Dr. A. Ramachandran's Diabetes Hospitals",
"id": "https://www.grid.ac/institutes/grid.468157.9",
"name": [
"Dr A Ramachandran's Diabetes Hospitals, Chennai, India."
],
"type": "Organization"
},
"familyName": "Ramachandran",
"givenName": "Ambady",
"type": "Person"
},
{
"affiliation": {
"name": [
"Diabetes Center at Al-Noor Specialist Hospital, Mecca, Saudi Arabia."
],
"type": "Organization"
},
"familyName": "Tayeb",
"givenName": "Khaled",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ministry of Health",
"id": "https://www.grid.ac/institutes/grid.415738.c",
"name": [
"FGBU \"Endocrinology Research Center\" Ministry of Health, Moscow, Russia."
],
"type": "Organization"
},
"familyName": "Vikulova",
"givenName": "Olga",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Sydney",
"id": "https://www.grid.ac/institutes/grid.1013.3",
"name": [
"Royal Prince Alfred Hospital Diabetes Centre, University of Sydney, Sydney, Australia."
],
"type": "Organization"
},
"familyName": "Wong",
"givenName": "Jencia",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Monash University",
"id": "https://www.grid.ac/institutes/grid.1002.3",
"name": [
"Baker Heart and Diabetes Institute, Level 4, Alfred Centre, 99 Commercial Road, Melbourne, VIC, 3004, Australia.",
"Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia."
],
"type": "Organization"
},
"familyName": "Shaw",
"givenName": "Jonathan E",
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.2337/dc08-9025",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011439066"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2337/dc14-2441",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021071301"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/pds.1802",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022111144"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/pds.1802",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022111144"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa0802743",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022234833"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/dom.12407",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023088966"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2337/dc10-0678",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024476317"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1177/1060028013503624",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024844618"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1177/1060028013503624",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024844618"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0140-6736(16)00618-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031632807"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa0806470",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034293538"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.pcd.2015.03.009",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040969804"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1185/03007995.2014.952716",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048331418"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.diabres.2016.06.018",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051255667"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.7326/0003-4819-159-4-201308200-00007",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1073713807"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3238/arztebl.2009.0664",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1077989099"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2337/dc16-1974",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1091190806"
],
"type": "CreativeWork"
}
],
"datePublished": "2019-04-08",
"datePublishedReg": "2019-04-08",
"description": "AIMS: The impact of introducing new classes of glucose-lowering medication (GLM) on diabetes management remains unclear, especially outside North America and Western Europe. Therefore, we aimed to analyse trends in glycaemic control and the usage of new and old GLMs in people with type 2 diabetes from 2006 to 2015.\nMETHODS: Summary data from clinical services from nine countries outside North America and Western Europe were collected and pooled for statistical analysis. Each site summarized individual-level data from out-patient medical records for 2006 and 2015. Data included: demographics; HbA1c and fasting plasma glucose levels; and the proportions of patients taking GLM as monotherapy, combination therapy and/or insulin.\nRESULTS: Between 2006 and 2015, glycaemic control remained stable, although body mass index and duration of diabetes increased in most sites. The proportion of people on GLM increased, and the therapeutic regimens became more complex. There were increases in the use of insulin and triple therapy in most sites, while monotherapy, particularly in relation to sulphonylureas, decreased. Despite the introduction of new GLMs, such as DPP-4 inhibitors, insulin use increased over time.\nCONCLUSIONS: There was no clear evidence that the use of new classes of GLMs was associated with improvements in glycaemic control or reduced the reliance on insulin. These findings were consistent across a range of economic and geographic settings.",
"genre": "research_article",
"id": "sg:pub.10.1007/s00592-018-01284-4",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1008525",
"issn": [
"0940-5429",
"1432-5233"
],
"name": "Acta Diabetologica",
"type": "Periodical"
}
],
"name": "Diabetes management and treatment approaches outside of North America and West Europe in 2006 and 2015.",
"productId": [
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00592-018-01284-4"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1113301040"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"9200299"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"30963308"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00592-018-01284-4",
"https://app.dimensions.ai/details/publication/pub.1113301040"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-15T08:48",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000374_0000000374/records_119717_00000001.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007/s00592-018-01284-4"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00592-018-01284-4'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00592-018-01284-4'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00592-018-01284-4'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00592-018-01284-4'
This table displays all metadata directly associated to this object as RDF triples.
251 TRIPLES
20 PREDICATES
39 URIs
16 LITERALS
6 BLANK NODES